100627-39-2

Usage

Uses

Used in Organic Chemical Synthesis:
METHYL 2-[(3-ETHOXYCARBONYL-PROPYL)-(TOLUENE-4-SULFONYL)-AMINO]-BENZOATE is used as a reagent in organic chemical synthesis for the production of various compounds. Its unique chemical structure allows it to participate in a range of reactions, making it a valuable component in the synthesis of new molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, METHYL 2-[(3-ETHOXYCARBONYL-PROPYL)-(TOLUENE-4-SULFONYL)-AMINO]-BENZOATE is used in research and development for the creation of new drugs and pharmaceuticals. Its unique properties and chemical structure make it a promising candidate for the development of novel therapeutic agents.
Used in Chemical Reactions:
METHYL 2-[(3-ETHOXYCARBONYL-PROPYL)-(TOLUENE-4-SULFONYL)-AMINO]-BENZOATE is used as a reagent in various chemical reactions, facilitating the formation of desired products. Its presence in these reactions can improve the efficiency and selectivity of the processes, leading to the production of high-quality end products.

Upstream product

• 2969-81-5 Ethyl 4-bromobutyrate 
• 50998-74-8 methyl N-tosylanthranilate 
• 134-20-3 2-carbomethoxyaniline 
• 98-59-9 p-toluenesulfonyl chloride 
• 27126-43-8 N-(3-ethoxycarbonyl-propyl)-anthranilic acid methyl ester 

Downstream Products

• 851044-96-7 5-oxo-1-tosyl-2,3,4,5-tetrahydro-1H-benzo[b]azepine-4-carboxylic acid methyl ester 
• 54620-98-3 ethyl 5-oxo-1-tosyl-2,3,4,5-tetrahydro-1H-benzo[b]azepine-4-carboxylate 
• 1261275-80-2 C₃₃H₃₁N₃O₃S 
• 1261275-78-8 C₃₂H₂₉N₅O₃S 
• 1261275-76-6 C₃₄H₂₇N₃O₃S₂ 
• 1261275-72-2 C₃₃H₂₉F₂N₅O₃S 
• 1261275-70-0 C₃₆H₂₈FN₃O₃S 
• 1261275-68-6 C₃₂H₂₇F₂N₅O₃S 
• 1261275-65-3 C₂₉H₂₃BrN₄O₃S 
• 1261275-61-9 C₃₄H₃₂N₄O₃S 
• 1261275-59-5 C₃₀H₂₄IN₃O₃S 
• 1261275-57-3 C₂₉H₂₃BrN₄O₃S 
• 1261277-27-3 C₂₉H₂₃BrN₄O₃S 
• 1261277-25-1 C₂₉H₂₄ClN₅O₃S 

Relevant academic research and scientific papers

Stereochemistry of N-Benzoyl-5-substituted-1-benzazepines Revisited: Synthesis of the Conformationally Biased Derivatives and Revision of the Reported Structure

The syn (aR?,5R?) and anti (aS?,5R?) diastereomers of N-benzoyl-C5-substituted-1-benzazepines originating in the chiralities at C5 and the Ar-N(C=O) axis were first stereoselectively synthesized by biasing the conformation with a substituent at C6 and C9, respectively. Detailed examination of the stereochemistry (i.e., conformation and configuration) of these N-benzoyl-1-benzazepines by X-ray crystallographic analysis, VT NMR, and DFT calculations revealed new physicochemical aspects of these heterocycles including revision of the stereochemistry previously reported.

ANTI-RSV COMPOUNDS

The present invention relates to anti-RSV compounds of Formula (I) and methods for use of the compounds in the treatment and prevention of RSV infection.

VASOPRESSIN V1A ANTAGONISTS

The present invention concerns compounds inter alia according to general formula 1a. Compounds according to the invention are vasopressin V 1a receptor antagonists. Pharmaceutical compositions of the compounds are useful as treatment of dysmenorrhoea.

COMPOUNDS AND METHODS FOR TREATING DYSLIPIDEMIA

Compounds of formula I wherein n, m, p, q, Y, R1 R2, R3, R4, R5, and R6 are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating artherosclerosis and its sequelae.